Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mei Pharma Inc
(NQ:
MEIP
)
2.980
-0.160 (-5.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Mei Pharma Inc
< Previous
1
2
3
4
Next >
MEI Pharma Postpones Special Meeting of Shareholders
July 13, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals
July 11, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals
July 07, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals
July 05, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals
June 29, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Responds to Anson and Cable Car
June 27, 2023
From
MEI Pharma, Inc.
Via
Business Wire
Anson Funds and Cable Car Capital Issue Statement Regarding the Inferior Proposed Transaction between MEI Pharma and Infinity Pharmaceuticals
June 27, 2023
From
Anson Funds Management LP
Via
GlobeNewswire
MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates
June 15, 2023
From
Infinity Pharmaceuticals, Inc.
Via
Business Wire
MEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successor
June 13, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D. and Appointment of David M. Urso as Successor
June 02, 2023
From
MEI Pharma, Inc.
Via
Business Wire
Anson Funds and Cable Car Capital Issue Statement Regarding MEI Pharma’s Rejection of Their Acquisition Proposal
June 01, 2023
From
Anson Funds Management LP
Via
GlobeNewswire
MEI Pharma Board of Directors Rejects Unsolicited Proposal
June 01, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal
May 30, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Update of Ongoing Phase 1 Study Evaluating Oral CDK9 Inhibitor Voruciclib Alone and in Combination with Venetoclax in Patients with Acute Myeloid Leukemia or B-Cell Malignancies
May 23, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Reports Third Quarter Fiscal Year 2023 Results and Operational Highlights
May 11, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces 1-for-20 Reverse Stock Split
April 14, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEIP STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of MEI Pharma, Inc. Is Fair to Shareholders
February 23, 2023
From
Halper Sadeh LLC
Via
Business Wire
MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates
February 23, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Reports Second Quarter Fiscal Year 2023 Results and Operational Highlights
February 09, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Adjournment of Annual Meeting of Stockholders
December 06, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Initiates Strategic Realignment
December 05, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma and Kyowa Kirin Announce Discontinuation of Zandelisib Development Outside of Japan Following Recent FDA Meeting
December 05, 2022
From
MEI Pharma, Inc.
Via
Business Wire
Kyowa Kirin and MEI Pharma Announce Topline Data from the Phase 2 MIRAGE Study Evaluating Zandelisib in Patients with Indolent B-cell non-Hodgkin’s Lymphoma in Japan
November 18, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Reports First Quarter Fiscal Year 2023 Results and Operational Highlights
November 14, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma and Kyowa Kirin Announce Acceptance of Three Abstracts for Presentation at the American Society of Hematology Annual Meeting 2022
November 03, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
October 03, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Changes to Board of Directors
September 22, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Reports Fiscal Year 2022 Results and Operational Highlights
September 08, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022
September 06, 2022
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
September 01, 2022
From
MEI Pharma, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.